Ostensibly they downgraded the stock in July 07 from buy to neutral, but never told the public they had upgraded.



Jonathan Block is normally very good, but something is wrong on SRH's tracking changes.


I would expect that ABAX got caught short on their VET disc and could not supply as all new production included the heart worm test, which they could not deliver until the FDA approval was in place - consequently disc sales will be down from target, but there will be catch up next Q.